Agilent Adds to Dako Omnis Instrument Portfolio

Agilent Technologies Inc. will soon introduce three new models to its Dako Omnis instrument lineup: Agilent Dako Omnis 110, 165, and 165 Duo—designed to meet the evolving needs of any size pathology laboratory. The new instruments aim to provide labs with the flexibility to tailor their staining solutions according to volume, workflow, and diagnostic requirements.

Scalable Solutions for Every Lab

• Dako Omnis 110: Built for precision in low-medium volume labs, delivering up to 110 IHC slides per day with dependable performance.
• Dako Omnis 165: Engineered for efficiency in medium-high volume labs, delivering up to 165 IHC slides per day with seamless consistency.
• Dako Omnis 165 Duo: Designed for ultimate flexibility in medium-high volume labs, delivering simultaneous IHC and ISH with maximum throughput and confidence.

Building on the success of the original Dako Omnis, all models feature continuous, case-based processing and shared reagents, enabling labs to streamline workflows and reduce turnaround times. A newly integrated direct connection for de-ionized water and non-hazardous waste further reduces handling time.

During testing, Jessica Barbour, senior biomedical scientist at Aberdeen Royal Infirmary, stated, “The addition of the direct connection is beneficial, provided there is access to direct deionized water. It is also advantageous to be able to empty the waste while the machine is operational. In the past, there have been instances where non-hazardous waste was not emptied in the morning, which consequently limited the number of slides we could run throughout the day.”

The new Agilent Dako Omnis instrument family will debut next month at the European Congress of Pathology (Sept. 6–10), and the National Society for Histotechnology (Sept. 26–30). Initial availability will be to the United States., Europe, and Australia.

“We recognize that pathology labs are under increasing pressure from rising test volumes, limited staffing, and growing diagnostic complexity,” stated Majken Nielsen, associate vice president of marketing and product management in the Clinical Diagnostics Division at Agilent. ‘This solution was developed in direct response to those challenges. Built on customer feedback, these instruments are designed to simplify workflows, enhance diagnostic efficiency, and help labs deliver timely, high-quality results.”

Agilent Technologies Inc. develops analytical and clinical laboratory technologies. Its full range of solutions includes instruments, software, services, and expertise that answer customers’ most challenging questions. The company generated $6.51 billion in fiscal 2024 revenue and employs approximately 18,000 people worldwide.